ライフサイエンスコーパス: vasectomy

1 testis occur in human infertility and after vasectomy.

2 te cancer, including 641 who had undergone a vasectomy.

3 nt tolerogenic versus autoimmune response to vasectomy.

4 stantially by age at vasectomy or time since vasectomy.

5 observed by stage of disease or years since vasectomy.

6 In total, 12,321 men (25%) had vasectomies.

7 rts remain regarding the association between vasectomy, a common form of male contraception in the Un

8 alcohol consumption, oral contraceptive use, vasectomy and induced abortion are markers for high ster

9 We also examined the association between vasectomy and prostate cancer incidence among 66,542 men

10 Methods We examined the association between vasectomy and prostate cancer mortality among 363,726 me

11 sults suggest no overall association between vasectomy and prostate cancer.

12 Sound to evaluate the relation between prior vasectomy and the risk of prostate cancer.

13 Patients who had undergone vasectomy and those who had a pH less than 5 or greater

14 d before and after surgery (scrotal approach vasectomy) and either received saline, meloxicam or bupi

15 condoms, intrauterine device, foam, spousal vasectomy) and infertility with ovarian cancer risk amon

16 aception exist (i.e. withdrawal, condoms and vasectomy), and these are acknowledged as woefully inade

17 es, 3 cholecystectomies, 3 hysterectomies, 3 vasectomies, and 1 each spinal fusion, appendectomy, eye

18 e methods of male contraception, condoms and vasectomy, and a large majority would be interested in n

19 For men, the only choices are condoms and vasectomy, and most current efforts to develop new contr

20 records on medical history, including prior vasectomy, anthropometric measures, family history of pr

21 Condoms and vasectomy are male-controlled family planning methods bu

22 ed information on vasectomy status (15% with vasectomy) at recruitment and were followed for incidenc

23 prostate cancer in men who have undergone a vasectomy compared with men who have not.

24 d men presenting for fertility evaluation or vasectomy consultation with proven biological paternity.

25 option for couples less than 15 years since vasectomy, couples interested in more than one child, co

26 evels of people who self-select for smoking, vasectomy, etc., at the time that self-selection is made

27 25 versus 0 MET-hours), controlling for age, vasectomy, history of diabetes, height, smoking, and die

28 tomy reversal as a treatment option for post-vasectomy infertility.

29 Purpose Vasectomy is a commonly used form of male sterilization,

30 Vasectomy is a well accepted global contraceptive approa

31 Our data support the hypothesis that vasectomy is associated with a modest increased incidenc

32 Vasectomy leads to rapid epithelial cell apoptosis and n

33 imate did not differ substantially by age at vasectomy or time since vasectomy.

34 ve methods are either not easily reversible (vasectomy) or not sufficiently effective (condom).

35 d for chronic testicular or groin pain, post-vasectomy pain, sports hernia pain, postnephrectomy, don

36 We performed a retrospective case series of vasectomy patients on TT with subsequent VR by a single

37 f males on testosterone therapy (TT) seeking vasectomy reversal (VR) is rising.

38 ale infertility and offers an alternative to vasectomy reversal as a treatment option for post-vasect

39 Vasectomy reversal should be considered the ideal option

40 platform in microsurgical procedures such as vasectomy reversal, varicocelectomy, denervation of the

41 platform in microsurgical procedures such as vasectomy reversal, varicocelectomy, microsurgical dener

42 ls develop antibodies against Sp17 following vasectomy, Sp17 is likely to be a highly immunogenic pro

43 aged 35 to 79 years, provided information on vasectomy status (15% with vasectomy) at recruitment and

44 differential participation rates due to both vasectomy status and a family history of prostate cancer

45 estimate for prostate cancer associated with vasectomy tended to be increased among men who had a fat

46 pliance (condoms) and limited reversibility (vasectomy); thus many couples desire other options.

47 al disease, infection, or surgery (including vasectomy) underwent gray-scale imaging, color Doppler i

48 ds ratio for prostate cancer associated with vasectomy was 0.86 (95% confidence interval 0.57-1.32) a

49 Vasectomy was associated with a small increased risk of

50 Purpose In a recent large prospective study, vasectomy was associated with modestly higher risk of pr

51 Vasectomy was not associated with death due to prostate

52 In the CPS-II Nutrition Cohort, vasectomy was not associated with either overall prostat

53 Results In the CPS-II cohort, vasectomy was not associated with prostate cancer mortal

54 Vasectomy was not associated with prostate cancer risk (

55 Vasectomy was not associated with the risk of low-grade

56 To understand the long-term sequelae of vasectomy, we investigated the early immune response in

57 ation and 573 women whose partners underwent vasectomy were followed in a multicenter, prospective co

58 ajority of men who have previously undergone vasectomy when the reconstruction is performed by an exp

59 y limited to unreliable condoms and invasive vasectomies with questionable reversibility.

60 ctive cohorts do not support associations of vasectomy with either prostate cancer incidence or prost

61 investigated the prospective association of vasectomy with prostate cancer in a large European cohor

62 Therefore, we assessed the associations of vasectomy with prostate cancer incidence and mortality i

63 We estimated the association of vasectomy with prostate cancer risk overall, by tumor su